BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld
BioWorld
April 29, 2010
View Archived Issues
For Now, MS Twin Study Yields More Questions, Not Answers
Read More
Lycera's Progress Triggers $11M in Second Part of Series A Round
Read More
Other News To Note
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Huntington's Drug Snagged on Statistics; Another Trial Needed?
Shares of NeuroSearch A/S sank 30 percent when it turned out the firm's positive Phase III Huntington's disease trial was not quite so positive after all. (BioWorld Today)
Read More
More Bush-Era Stem Cell Lines OK'd by NIH for Federal Funds
Read More
